NASDAQ · SPTX
Seaport Therapeutics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SPTX: Nov 2, 2026
Seaport Therapeutics, Inc. Common Stock is estimated to report earnings on 11/02/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.58.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.58 | $-0.54 | $-0.65 | 3 |
| Dec 2026 | $-0.61 | $-0.57 | $-0.69 | 3 |
| Mar 2027 | $-0.67 | $-0.62 | $-0.71 | 2 |
| Jun 2027 | $-0.68 | $-0.64 | $-0.72 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · RTTNews · BNK Invest- Fintel · Oct 14, 2:16 PM EDTCanaccord Genuity Initiates Coverage of Seaport Therapeutics with Buy RatingFintel reports that on October 14, 2026, Canaccord Genuity initiated coverage of Seaport Therapeutics (NASDAQGS:SPTX) with a Buy recommendation.Prior to this coverage initiation, the stock closed at $16.08 on October 13, 2026. This pre-action close reflects recent downward moveme
- Fintel · Sep 25, 10:19 PM EDTRaymond James Initiates Coverage of Seaport Therapeutics at Strong BuyFintel reports that on September 25, 2026, Raymond James initiated coverage of Seaport Therapeutics (NASDAQGS:SPTX) with a Strong Buy recommendation.Prior to this action, other firms also updated their outlooks on Seaport Therapeutics. On September 10, 2026, HC Wainwright & C
- RTTNews · Sep 9, 8:17 AM EDTSeaport Reports Positive GlyphAllo Driving Trial Results In Healthy Volunteers(RTTNews) – Seaport Therapeutics, Inc. (SPTX) announced positive topline results from a Phase 1 driving simulation trial evaluating GlyphAllo (SPT-300 or Glyph Allopregnanolone), a novel oral prodrug of allopregnanolone, in healthy volunteers.
- RTTNews · Aug 27, 5:22 AM EDTBiotech Stocks At 52-Week Highs – CRDL, NEO, SPTX, RAPP, CGEM(RTTNews) – The following biotech stocks reached a 52-week high on August 26, 2026, as clinical trials continued enrolment and companies reached various regulatory milestones.
- BNK Invest · Jun 24, 11:24 AM EDTWednesday 6/24 Insider Buying Report: PWRL, SPTXAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys. At Powerlaw, a filing with the SEC revealed that on Monday, Chief Executive Officer
- RTTNews · Jun 9, 3:35 AM EDTSeaport Therapeutics Reports Wider Net Loss In Q1; Expects Phase 2b BUOY-1 Trial Data In H1,2027(RTTNews) – Seaport Therapeutics, Inc. (SPTX), reported a wider net loss for its first financial quarter ended March 31, 2026, and provided near term milestone update.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Seaport Therapeutics, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.